Alan Lotvin - Feb 21, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:26 PM
Previous filing
Feb 2, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +86K +140.15% $0.00 147K Feb 21, 2022 Direct F1
holding CVS Common Stock 492 Feb 21, 2022 By Children's Trusts
holding CVS Common Stock (restricted) 5.83K Feb 21, 2022 Direct
holding CVS Stock Unit 30K Feb 21, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 557 Feb 21, 2022 Common Stock 557 $1.00 Direct F2, F3
holding CVS Stock Option 27.4K Feb 21, 2022 Common Stock 27.4K $104.82 Direct F4
holding CVS Stock Option 32.9K Feb 21, 2022 Common Stock 32.9K $78.05 Direct F5
holding CVS Stock Option 22.5K Feb 21, 2022 Common Stock 22.5K $62.21 Direct F6
holding CVS Stock Option 70.7K Feb 21, 2022 Common Stock 70.7K $54.19 Direct F7
holding CVS Stock Option 141K Feb 21, 2022 Common Stock 141K $58.34 Direct F8, F9
holding CVS Stock Option 121K Feb 21, 2022 Common Stock 121K $74.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F8 The number of shares subject to the option were calculated using a 30-day average price.
F9 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.